The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications, Blood, vol.117, issue.19, pp.5019-5051, 2011. ,
DOI : 10.1182/blood-2011-01-293050
Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes, Seminars in Cancer Biology, vol.21, issue.5, pp.293-301, 2011. ,
DOI : 10.1016/j.semcancer.2011.09.010
Mantle cell lymphoma epidemiology: a population-based study in France, Annals of Hematology, vol.91, issue.11, pp.1327-1360, 2014. ,
DOI : 10.1007/s00277-014-2049-5
Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches, Cancer Control J Moffitt Cancer Cent, vol.19, pp.227-262, 2012. ,
Borrelia infection and risk of non-Hodgkin lymphoma, Blood, vol.111, issue.12, pp.5524-5533, 2008. ,
DOI : 10.1182/blood-2007-08-109611
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph), Blood, vol.109, issue.8, pp.3479-88, 2007. ,
DOI : 10.1182/blood-2006-06-031948
Tumor Necrosis Factor (TNF) and Lymphotoxin-?? (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium, American Journal of Epidemiology, vol.171, issue.3, pp.267-76, 2010. ,
DOI : 10.1093/aje/kwp383
Current treatment standards and emerging strategies in mantle cell lymphoma, Hematology, vol.2009, issue.1, pp.542-51, 2009. ,
DOI : 10.1182/asheducation-2009.1.542
Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management, American Journal of Hematology, vol.104, issue.6, pp.604-613, 2012. ,
DOI : 10.1002/ajh.23176
Survival trends in mantle cell lymphoma in the United States over 16 years 1992???2007, Leukemia & Lymphoma, vol.14, issue.1, pp.1488-93, 2007. ,
DOI : 10.1002/ajh.21036
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma, Blood, vol.111, issue.2, pp.558-65, 2008. ,
DOI : 10.1182/blood-2007-06-095331
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing, New England Journal of Medicine, vol.366, issue.10, pp.883-92, 2012. ,
DOI : 10.1056/NEJMoa1113205
Effectiveness, safety and costs of orphan drugs: an evidence-based review, BMJ Open, vol.5, p.7199, 2015. ,
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma, New England Journal of Medicine, vol.369, issue.6, pp.507-523, 2013. ,
DOI : 10.1056/NEJMoa1306220
Mantle cell lymphoma: evolving management strategies, Blood, vol.125, issue.1, pp.48-55, 2015. ,
DOI : 10.1182/blood-2014-05-521898
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets, Nature Medicine, vol.559, issue.2, pp.202-210, 2013. ,
DOI : 10.1038/leu.2009.151
The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma, Leukemia, vol.21, issue.1, pp.210-212, 2014. ,
DOI : 10.1038/leu.2013.216
Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma, Oncotarget, vol.6, issue.11, pp.8750-8759, 2015. ,
DOI : 10.18632/oncotarget.3275
Haematological cancer and quality of life: a systematic literature review, Blood Cancer Journal, vol.46, issue.4, p.305, 2015. ,
DOI : 10.1016/S1470-2045(07)70287-5
Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma, Cancer, vol.112, issue.3, pp.672-80, 2013. ,
DOI : 10.1002/cncr.27781
Quality of Life Among Long-Term Survivors of Non-Hodgkin Lymphoma: A Follow-Up Study, Journal of Clinical Oncology, vol.31, issue.2, pp.272-281, 2013. ,
DOI : 10.1200/JCO.2011.40.6249
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment, Seminars in Radiation Oncology, vol.13, issue.3, pp.176-81, 2003. ,
DOI : 10.1016/S1053-4296(03)00031-6
CUMULATIVE ILLNESS RATING SCALE, Journal of the American Geriatrics Society, vol.22, issue.5, pp.622-628, 1968. ,
DOI : 10.1111/j.1532-5415.1968.tb02103.x
The MOS 36-ltem Short-Form Health Survey (SF-36), Medical Care, vol.30, issue.6, pp.473-83, 1992. ,
DOI : 10.1097/00005650-199206000-00002
The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective Evidence from the EuroQol BIOMED Research Programme [Internet], 2003. ,
The Development and Validation of a Measure of Health-Related Quality of Life for Non-Hodgkin???s Lymphoma: The Functional Assessment of Cancer Therapy???Lymphoma (FACT-Lym), Lymphoma, vol.13, issue.9, pp.1-9, 2013. ,
DOI : 10.1007/BF02310555
SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma, Blood, vol.121, issue.12, pp.2175-85, 2013. ,
DOI : 10.1182/blood-2012-06-438937
Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells, Cancer Research, vol.72, issue.17, pp.4562-73, 2012. ,
DOI : 10.1158/0008-5472.CAN-12-0487
BH3 profiling identifies heterogeneous dependency on Bcl-2 family members in multiple myeloma and predicts sensitivity to BH3 mimetics, Leukemia, vol.120, issue.3, pp.761-765, 2016. ,
DOI : 10.1016/j.ymeth.2013.04.006
URL : https://hal.archives-ouvertes.fr/inserm-01411102
The microenvironment in mantle cell lymphoma: Cellular and molecular pathways and emerging targeted therapies, Seminars in Cancer Biology, vol.21, issue.5, pp.308-320, 2011. ,
DOI : 10.1016/j.semcancer.2011.09.006
Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research, Laboratory Investigation, vol.13, issue.7, pp.806-823, 2014. ,
DOI : 10.1093/bioinformatics/btm311
R: A language and environment for statistical computing [Internet] Vienna: R Foundation for Statistical Computing Available from: URL http ,